TP53 and neoplasm: During the carcinogenic process, the TP53 mutant does not initiate tumor formation, but tumors developing from areas exhibiting biallelic TP53 inactivation develop larger tumors in a display of chromosomal instability, which are conditions that favor ESCC development [19].